Non-heartbeating donation of kidneys for transplantation

Nature Clinical Practice Nephrology

Volumn 3, Issue 3, 2007, Pages 154-163

  Kootstra, Gauke ^a   Van Heurn, Ernest ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Delayed graft function; Donation after cardiac death; Kidney transplantation; Non heartbeating donation; Organ shortage

Indexed keywords

CYCLOSPORIN A;

BRAIN DAMAGE; CADAVER KIDNEY; DELAYED GRAFT FUNCTION; ENZYME RELEASE; GRAFT FAILURE; GRAFT PRESERVATION; GRAFT SURVIVAL; HEART ARREST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY PRESERVATION; KIDNEY TRANSPLANTATION; LIVING DONOR; PRIORITY JOURNAL; REVIEW;

CADAVER; HEART ARREST; HUMANS; KIDNEY TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 33847292784     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0426     Document Type: Review

References (66)

1. [No authors listed] (1968) A definition of irreversible coma: Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. JAMA 205: 337-340
2. van der Vliet JA et al. (1980) Non-heartbeating donors; is it worthwhile? Proc Eur Dial Transplant Assoc 17: 445-449
3. Koffman CG et al. (1993) Comparative study of the use of systolic and asystolic kidney donors between 1988 and 1991. The South Thames Transplant Group. Transplant Proc 25: 1527-1529
4. Kootstra G et al. (1995) Categories of non-heartbeating donors. Transplant Proc 27: 2893-2894
5. Garcia-Rinaldi R et al. (1975) In situ preservation of cadaver kidneys for transplantation: laboratory observations and clinical application. Ann Surg 182: 576-584
6. Wilson CH et al. (2004) Evaluation of eight preservation solutions for endothelial in situ preservation. Transplantation 78: 1008-1013
7. Herdman R et al. (1998) The Institute of Medicine's report on non-heart-beating organ transplantation. Kennedy Inst Ethics J 8: 83-90
8. Wijnen RM et al. (1995) Outcome of transplantation of non-heart-beating donor kidneys. Lancet 345: 1067-1070
9. Metcalfe MS et al. (2001) A case-control comparison of the results of renal transplantation from heart-beating and non-heart-beating donors. Transplantation 71: 1556-1559
10. Weber M et al. (2002) Kidney transplantation from donors without a heartbeat. N Engl J Med 347: 248-255
11. Gok MA et al. (2002) Long-term renal function in kidneys from non-heart-beating donors: a single-center experience. Transplantation 74: 664-669
12. Sudhindran S et al. (2003) Outcome of transplantation using kidneys from controlled (Maastricht category 3) non-heart-beating donors. Clin Transplant 17: 93-100
13. Chapman J et al. (2006) Follow-up after renal transplantation with organs from donors after cardiac death. Transpl Int 19: 715-719
14. Cho YW et al. (1998) Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med 338: 221-225
15. Nicholson ML et al. (2000) A comparison of the results of renal transplantation from non-heart-beating, conventional cadaveric, and living donors. Kidney Int 58: 2585-2591
16. Keizer KM et al. (2005) Non-heart-beating donor kidneys in the Netherlands: allocation and outcome of transplantation. Transplantation 79: 1195-1199
17. Sanchez-Fructuoso A et al. (2004) Non-heart beating donors. Nephrol Dial Transplant 19 (Suppl 3): Siii26-Siii31
18. Alonso A et al. (2005) Renal transplantation from non-heart-beating donors: a single-center 10-year experience. Transplant Proc 37: 3658-3660
19. Cooper JT et al. (2004) Donation after cardiac death: the University of Wisconsin experience with renal transplantation. Am J Transplant 4: 1490-1494
20. Lee CY et al. (2005) Expanding the donor pool: use of renal transplants from non-heart-beating donors supported with extracorporeal membrane oxygenation. Clin Transplant 19: 383-390
21. Tanabe K et al. (1998) Long-term renal function in on-heart-beating donor kidney transplantation: a single-center experience. Transplantation 66: 1708-1713
22. Light JA et al. (1999) Long-term graft survival after transplantation with kidneys from uncontrolled nonheartbeating donors. Transplantation 68: 1910-1911
23. Alvarez J et al. (2000) Non-heart-beating donors from the streets: an increasing donor pool source. Transplantation 70: 314-317
24. Hattori R et al. (2003) Long-term outcome of kidney transplant using non-heart-beating donor: multicenter analysis of factors affecting graft survival. Clin Transplant 17: 518-521
25. de Boer J et al. (1999) Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl Int 12: 447-453
26. Ploeg RJ et al. (1992) Effect of preservation solution on results of cadaveric kidney transplantation. The European Multicentre Study Group. Lancet 340: 129-137
27. Booster MH et al. (1994) University of Wisconsin solution is superior to histidine tryptophan ketoglutarate for preservation of ischemically damaged kidneys. Transplantation 58: 979-984
28. Roels L et al. (1998) Inferior outcome of cadaveric kidneys preserved for more than 24 hr in histidine-tryptophan-ketoglutarate solution. Leuven Collaborative Group for Transplantation. Transplantation 66: 1660-1664
29. Schmitz V et al. (2006) Impact of organ preservation using HTK for graft flush and subsequent storage in UW in rat kidney transplantation. Eur Surg Res 38: 388-398
30. Balupuri S et al. (2000) The trouble with kidneys derived from the non heart-beating donor: a single center 10-year experience. Transplantation 69: 842-846
31. St Peter SD et al. (2002) Liver and kidney preservation by perfusion. Lancet 359: 604-613
32. Wight JP et al. (2003) Pulsatile machine perfusion vs. cold storage of kidneys for transplantation: a rapid and systematic review. Clin Transplant 17: 293-307
33. Kozaki K et al. (2000) Prediction of kidney nonfunction after transplantation with machine perfusion preservation. Transplant Proc 32: 275-276
34. Wilson CH et al. (2004) Weight increase during machine perfusion may be an indicator of organ and in particular, vascular damage. Ann Transplant 9: 31-32
35. Daemen JH et al. (1995) Viability assessment of non-heart-beating donor kidneys during machine preservation. Transplant Proc 27: 2906-2907
36. Daemen JW et al. (1997) Glutathione S-transferase as predictor of functional outcome in transplantation of machine-preserved non-heart-beating donor kidneys. Transplantation 63: 89-93
37. Kievit JK et al. (1997) Release of alpha-glutathione S-transferase (alpha GST) and pi-glutathione S-transferase (pi GST) from ischemic damaged kidneys into the machine perfusate-relevance to viability assessment. Transplant Proc 29: 3591-3593
38. Van Kreel BK et al. (2002) Functional relationship of alpha-glutathione S-transferase and glutathione S-transferase activity in machine-preserved non-heartbeating donor kidneys. Transpl Int 15: 546-549
39. Gok MA et al. (2003) Use of two biomarkers of renal ischemia to assess machine-perfused non-heart-beating donor kidneys. Clin Chem 49: 172-175
40. de Vries B et al. (2004) Reduction of circulating redoxactive iron by apotransferrin protects against renal ischemia-reperfusion injury. Transplantation 77: 669-675
41. de Vries B et al. (2006) Redox-active iron released during machine perfusion predicts viability of ischemically injured deceased donor kidneys. Am J Transplant 6: 2686-2693
42. Snoeijs MG et al. (2006) Kidney transplantation using elderly non-heart-beating donors: a single-center experience. Am J Transplant 6: 1066-1071
43. Ojo AO et al. (1997) Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 63: 968-974
44. Shoskes DA and Cecka JM (1997) Effect of delayed graft function on short- and long-term kidney graft survival. Clin Transpl 297-303
45. McLaren AJ et al. (1999) Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant 13: 266-272
46. Gjertson DW (2000) Impact of delayed graft function and acute rejection on kidney graft survival. Clin Transpl 467-480
47. Brook NR et al. (2003) Non-heart beating donor kidneys with delayed graft function have superior graft survival compared with conventional heart-beating donor kidneys that develop delayed graft function. Am J Transplant 3: 614-618
48. Bains JC et al. (2005) Comparison of renal allograft fibrosis after transplantation from heart-beating and non-heart-beating donors. Br J Surg 92: 113-118
49. Gerstenkorn C et al. (2002) Outcome of renal allografts from non-heart-beating donors with delayed graft function. Transpl Int 15: 660-663
50. Renkens JJ et al. (2005) Outcome of nonheart-beating donor kidneys with prolonged delayed graft function after transplantation. Am J Transplant 5: 2704-2709
51. Gomez M et al. (1993) Cardiopulmonary bypass and profound hypothermia as a means for obtaining kidney grafts from irreversible cardiac arrest donors: cooling technique. Transplant Proc 25: 1501-1502
52. Sanchez-Fructuoso AI et al. (2000) Renal transplantation from non-heart beating donors: a promising alternative to enlarge the donor pool. J Am Soc Nephrol 11: 350-358
53. Ko WJ et al. (2000) Extracorporeal membrane oxygenation support of donor abdominal organs in non-heart-beating donors. Clin Transplant 14: 152-156
54. Magliocca JF et al. (2005) Extracorporeal support for organ donation after cardiac death effectively expands the donor pool. J Trauma 58: 1095-1101
55. Gok MA et al. (2003) How to improve the quality of kidneys from non-heart-beating donors: a randomised controlled trial of thrombolysis in non-heart-beating donors. Transplantation 76: 1714-1719
56. Mi H et al. (2005) Do recipients of kidneys from donors treated with streptokinase develop anti-streptokinase antibodies? Transplant Proc 37: 3272-3273
57. Grinyo JM et al. (2003) Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years. Transpl Int 16: 820-827
58. Sonoda T et al. (2003) Outcome of 3 years of immunosuppression with tacrolimus in more than 1,000 renal transplant recipients in Japan. Transplantation 75: 199-204
59. Wilson CH et al. (2005) Randomized clinical trial of daclizumab induction and delayed introduction of tacrolimus for recipients of non-heart-beating kidney transplants. Br J Surg 92: 681-687
60. Shemie SD et al. (2006) Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential. CMAJ 174: S13-S32
61. Bernat JL et al. (2006) Report of a National Conference on Donation after cardiac death. Am J Transplant 6: 281-291
62. D'Alessandro AM et al. (2004) Donation after cardiac death: the University of Wisconsin experience. Ann Transplant 9: 68-71
63. Merion RM et al. (2005) Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 294: 2726-2733
64. Nicholson ML et al. (1996) Work-load generated by the establishment of a non-heart beating kidney transplant programme. Transpl Int 9: 603-606
65. Brasile L et al. (2002) Overcoming severe renal ischemia: the role of ex vivo warm perfusion. Transplantation 73: 897-901
66. Terasaki PI et al. (1997) Strategy for eliminating the kidney shortage. Clin Transpl 265-267